...
机译:Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition
Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA;
Kolltan Pharmaceut Inc, New Haven, CT 06511 USA;
receptor tyrosine kinase; KIT; monoclonal antibody; targeted therapy; oncogenic mutant;